Molecular Mechanisms of Viral Immune Evasion Proteins to Inhibit MHC Class I Antigen Processing and Presentation

REFERENCES

• Lilley B. N., Ploeghm H. L. Viral modulation of antigen presentation: Manipulation of cellular targets in the ER and beyond. Immunol Rev 2005; 207: 126–144
   PubMed Web of Science ®Google Scholar
• Yewdell J. W., Bennink J. R. Mechanisms of viral interference with MHC class I antigen processing and presentation. Annu Rev Cell Dev Biol 1999; 15: 579–606
   PubMed Web of Science ®Google Scholar
• Trombetta E. S., Mellman I. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 2005; 23: 975–1028
   PubMed Web of Science ®Google Scholar
• Abele R., Tampe R. Modulation of the antigen transport machinery TAP by friends and enemies. FEBS Lett 2006; 580: 1156–1163
   Google Scholar
• Wrightham M. N., Stewart J. P., Janjua N. J., Pepper S. D., Sample C., Rooney C. M., Arrand J. R. Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 1995; 208: 521–530
   PubMed Web of Science ®Google Scholar
• Boname J. M., Stevenson P. G. MHC class I ubiquitination by a viral PHD/LAP finger protein. Immunity 2001; 15: 627–636
   PubMedGoogle Scholar
• Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., et al. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995; 375: 411–415
   PubMed Web of Science ®Google Scholar
• Tomazin R., Hill A. B., Jugovic P., York I., van Endert P., Ploegh H. L., et al. Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 1996; 15: 3256–3266
   PubMedGoogle Scholar
• Ahn K., Meyer T. H., Uebel S., Sempe P., Djaballah H., Yang Y., et al. Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 1996; 15: 3247–3255
   PubMed Web of Science ®Google Scholar
• Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P. M., Tampe R., et al. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995; 375: 415–418
   PubMed Web of Science ®Google Scholar
• Kyritsis C., Gorbulev S., Hutschenreiter S., Pawlitschko K., Abele R., Tampe R. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. J Biol Chem 2001; 276: 48031–48039
   Google Scholar
• Lehner P. J., Karttunen J. T., Wilkinson G. W., Cresswell P. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. Proc Natl Acad Sci U S A 1997; 94: 6904–6909
   Google Scholar
• Hengel H., Koopmann J. O., Flohr T., Muranyi W., Goulmy E., Hammerling G. J., et al. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 1997; 6: 623–632
   Google Scholar
• Ackerman A. L., Kyritsis C., Tampe R., Cresswell P. Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens. Proc Natl Acad Sci U S A 2003; 100: 12889–12894
   PubMed Web of Science ®Google Scholar
• Burgdorf S., Scholz C., Kautz A., Tampe R., Kurts C. Spatial and mechanistic separation of cross-presentation and endogenous antigen presentation. Nat Immunol 2008; 9: 558–566
   PubMed Web of Science ®Google Scholar
• Lipinska A. D., Koppers-Lalic D., Rychlowski M., Admiraal P., Rijsewijk F. A., Bienkowska-Szewczyk K., Wiertz E. J. Bovine herpesvirus 1 UL49.5 protein inhibits the transporter associated with antigen processing despite complex formation with glycoprotein M. J Virol 2006; 80: 5822–5832
   Google Scholar
• Verweij M. C., Koppers-Lalic D., Loch S., Klauschies F., de la Salle H., Quinten E., Lehner P. J., et al. The varicellovirus UL49.5 protein blocks the transporter associated with antigen processing (TAP) by inhibiting essential conformational transitions in the 6+6 transmembrane TAP core complex. J Immunol 2008; 181: 4894–4907
   Google Scholar
• Loch S., Klauschies F., Scholz C., Verweij M. C., Wiertz E. J., Koch J., Tampe R. Signaling of a varicelloviral factor across the endoplasmic reticulum membrane induces destruction of the peptide-loading complex and immune evasion. J Biol Chem 2008; 283: 13428–13436
   Google Scholar
• Bennett E. M., Bennink J. R., Yewdell J. W. F. M. and Brodsky, Cutting edge: Adenovirus E19 has two mechanisms for affecting class I MHC expression. J Immunol 1999; 162: 5049–5052
   PubMedGoogle Scholar
• Beier D. C., Cox J. H., Vining D. R., Cresswell P., Engelhard V. H. Association of human class I MHC alleles with the adenovirus E3/19K protein. J Immunol 1994; 152: 3862–3872
   Google Scholar
• Pande N. T., Powers C., Ahn K., Fruh K. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. J Virol 2005; 79: 5786–5798
   PubMed Web of Science ®Google Scholar
• Ashrafi G. H., Haghshenas M. R., Marchetti B., O'Brien P. M., Campo M. S. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I. Int J Cancer 2005; 113: 276–283
   PubMed Web of Science ®Google Scholar
• Ashrafi G. H., Tsirimonaki E., Marchetti B., O'Brien P. M., Sibbet G. J., Andrew L., Campo M. S. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene 2002; 21: 248–259
   PubMedGoogle Scholar
• Marchetti B., Ashrafi G. H., Tsirimonaki E., O'Brien P. M., Campo M. S. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene 2002; 21: 7808–7816
   PubMedGoogle Scholar
• Cohen J. I. Infection of cells with varicella-zoster virus down-regulates surface expression of class I major histocompatibility complex antigens. J Infect Dis 1998; 177: 1390–1393
   PubMed Web of Science ®Google Scholar
• Abendroth A., Arvin A. Varicella-zoster virus immune evasion. Immunol Rev 1999; 168: 143–156
   PubMedGoogle Scholar
• Hudson A. W., Blom D., Howley P. M., Ploegh H. L. The ER-lumenal domain of the HHV-7 immunoevasin U21 directs class I MHC molecules to lysosomes. Traffic 2003; 4: 824–837
   Google Scholar
• Binette J., Cohen E. A. Recent advances in the understanding of HIV-1 Vpu accessory protein functions. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4: 297–307
   Google Scholar
• Luo T., Foster J. L., Garcia J. V. Molecular determinants of Nef function. J Biomed Sci 1997; 4: 132–138
   PubMed Web of Science ®Google Scholar
• Lorenzo M. E., Jung J. U., Ploegh H. L. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J Virol 2002; 76: 5522–5531
   Google Scholar
• Ishido S., Wang C., Lee B. S., Cohen G. B., Jung J. U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 2000; 74: 5300–5309
   Google Scholar
• Bartee E., Mansouri M., Hovey Nerenberg B. T., Gouveia K., Fruh K. Downregulation of major histocompatibility complex class I by human ubiquitin ligases related to viral immune evasion proteins. J Virol 2004; 78: 1109–1120
   PubMed Web of Science ®Google Scholar
• Ishido S., Choi J. K., Lee B. S., Wang C., DeMaria M., Johnson R. P., et al. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 2000; 13: 365–374
   PubMed Web of Science ®Google Scholar
• Fruh K., Bartee E., Gouveia K., Mansouri M. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res 2002; 88: 55–69
   Google Scholar
• Mansouri M., Bartee E., Gouveia K., Hovey Nerenberg B. T., Barrett J., Thomas L., et al. The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J Virol 2003; 77: 1427–1440
   Google Scholar
• Chen M., Gerlier D. Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy. Viral Immunol 2006; 19: 349–362
   Google Scholar
• Newton K., Matsumoto M. L., Wertz I. E., Kirkpatrick D. S., Lill J. R., Tan J. Ubiquitin chain editing revealed by polyubiquitin linkage-specific antibodies. Cell 2008; 134: 668–678
   PubMed Web of Science ®Google Scholar
• Cook W. J., Jeffrey L. C., Carson M., Chen Z., Pickart C. M. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J Biol Chem 1992; 267: 16467–16471
   PubMed Web of Science ®Google Scholar
• Varadan R., Assfalg M., Haririnia A., Raasi S., Pickart C., Fushman D. Solution conformation of Lys63-linked di-ubiquitin chain provides clues to functional diversity of polyubiquitin signaling. J Biol Chem 2004; 279: 7055–7063
   PubMedGoogle Scholar
• Chau V., Tobias J. W., Bachmair A., Marriott D., Ecker D. J., Gonda D. K., Varshavsky A. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science 1989; 243: 1576–1583
   PubMed Web of Science ®Google Scholar
• Adhikari A., Xu M., Chen Z. J. Ubiquitin-mediated activation of TAK1 and IKK. Oncogene 2007; 26: 3214–3226
   PubMed Web of Science ®Google Scholar
• Sun L., Chen Z. J. The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 2004; 16: 119–126
   PubMed Web of Science ®Google Scholar
• Lehner P. J., Cresswell P. Recent developments in MHC-class-I-mediated antigen presentation. Curr Opin Immunol 2004; 16: 82–89
   PubMedGoogle Scholar
• Boname J. M., May J. S., Stevenson P. G. The murine gamma-herpesvirus-68 MK3 protein causes TAP degradation independent of MHC class I heavy chain degradation. Eur J Immunol 2005; 35: 171–179
   Google Scholar
• Wang X., Lybarger L., Connors R., Harris M. R., Hansen T. H. Model for the interaction of gammaherpesvirus 68 RING-CH finger protein mK3 with major histocompatibility complex class I and the peptide-loading complex. J Virol 2004; 78: 8673–8686
   Google Scholar
• Boname J. M., de Lima B. D., Lehner P. J., Stevenson P. G. Viral degradation of the MHC class I peptide loading complex. Immunity 2004; 20: 305–317
   Google Scholar
• Lybarger L., Wang X., Harris M. R., Virgin H. W. T., Hansen T. H. Virus subversion of the MHC class I peptide-loading complex. Immunity 2003; 18: 121–130
   Google Scholar
• Paulson E., Tran C., Collins K., Fruh K. KSHV-K5 inhibits phosphorylation of the major histocompatibility complex class I cytoplasmic tail. Virology 2001; 288: 369–378
   Google Scholar
• Means R. E., Ishido S., Alvarez X., Jung J. U. Multiple endocytic trafficking pathways of MHC class I molecules induced by a herpesvirus protein. Embo J 2002; 21: 1638–1649
   Google Scholar
• Yamamoto M., Okamoto T., Takeda K., Sato S., Sanjo H., Uematsu S., et al. Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat Immunol 2006; 7: 962–970
   PubMedGoogle Scholar
• Lewis M. J., Saltibus L. F., Hau D. D., Xiao W., Spyracopoulos L. Structural basis for non-covalent interaction between ubiquitin and the ubiquitin conjugating enzyme variant human MMS2. J Biomol NMR 2006; 34: 89–100
   Google Scholar
• Zou W., Papov V., Malakhova O., Kim K. I., Dao C., Li J., Zhang D. E. ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochem Biophys Res Commun 2005; 336: 61–68
   PubMedGoogle Scholar
• Murk J. L., Stoorvogel W., Kleijmeer M. J., Geuze H. J. The plasticity of multivesicular bodies and the regulation of antigen presentation. Semin Cell Dev Biol 2002; 13: 303–311
   Google Scholar
• Hirst J., Robinson M. S. Clathrin and adaptors. Biochim Biophys Acta 1998; 1404: 173–193
   PubMed Web of Science ®Google Scholar
• Winter V., Hauser M. T. Exploring the ESCRTing machinery in eukaryotes. Trends Plant Sci 2006; 11: 115–123
   PubMed Web of Science ®Google Scholar
• Bache K. G., Brech A., Mehlum A., Stenmark H. Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 2003; 162: 435–442
   PubMed Web of Science ®Google Scholar
• Clague M. J., Urbe S. Hrs function: Viruses provide the clue. Trends Cell Biol 2003; 13: 603–606
   PubMed Web of Science ®Google Scholar
• Stevenson P. G., Boname J. M., de Lima B., Efstathiou S. A battle for survival: Immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect 2002; 4: 1177–1182
   Google Scholar
• Doherty P. C., Christensen J. P., Belz G. T., Stevenson P. G., Sangster M. Y. Dissecting the host response to a gamma-herpesvirus. Philos Trans R Soc Lond B Biol Sci 2001; 356: 581–593
   PubMedGoogle Scholar
• Stevenson P. G., Efstathiou S., Doherty P. C., Lehner P. J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc Natl Acad Sci U S A 2000; 97: 8455–8460
   Google Scholar
• Stevenson P. G., May J. S., Smith X. G., Marques S., Adler H., Koszinowski U. H., et al. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus. Nat Immunol 2002; 3: 733–740
   PubMedGoogle Scholar
• Duncan L. M., Piper S., Dodd R. B., Saville M. K., Sanderson C. M., Luzio J. P., Lehner P. J. Lysine-63-linked ubiquitination is required for endolysosomal degradation of class I molecules. Embo J 2006; 25: 1635–1645
   PubMedGoogle Scholar
• Piguet V., Schwartz O., Le Gall S., Trono D. The downregulation of CD4 and MHC-I by primate lentiviruses: A paradigm for the modulation of cell surface receptors. Immunol Rev 1999; 168: 51–63
   PubMed Web of Science ®Google Scholar
• Polishchuk R. S., San Pietro E., Di Pentima A., Tete S., Bonifacino J. S. Ultrastructure of long-range transport carriers moving from the trans Golgi network to peripheral endosomes. Traffic 2006; 7: 1092–1103
   PubMedGoogle Scholar
• Robinson M. S., Bonifacino J. S. Adaptor-related proteins. Curr Opin Cell Biol 2001; 13: 444–453
   PubMed Web of Science ®Google Scholar
• Teuchert M., Schafer W., Berghofer S., Hoflack B., Klenk H. D., Garten W. Sorting of furin at the trans-Golgi network. Interaction of the cytoplasmic tail sorting signals with AP-1 Golgi-specific assembly proteins. J Biol Chem 1999; 274: 8199–8207
   Google Scholar
• Roeth J. F., Williams M., Kasper M. R., Filzen T. M., Collins K. L. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J Cell Biol 2004; 167: 903–913
   PubMed Web of Science ®Google Scholar
• del Val M., Hengel H., Hacker H., Hartlaub U., Ruppert T., Lucin P., Koszinowski U. H. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. J Exp Med 1992; 176: 729–738
   Google Scholar
• Hengel H., Lucin P., Jonjic S., Ruppert T., Koszinowski U. H. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 1994; 68: 289–297
   Google Scholar
• Holtappels R., Grzimek N. K., Simon C. O., Thomas D., Dreis D., Reddehase M. J. Processing and presentation of murine cytomegalovirus pORFm164-derived peptide in fibroblasts in the face of all viral immunosubversive early gene functions. J Virol 2002; 76: 6044–6053
   Google Scholar
• Holtappels R., Gillert-Marien D., Thomas D., Podlech J., Deegen P., Herter S., et al. Cytomegalovirus encodes a positive regulator of antigen presentation. J Virol 2006; 80: 7613–7624
   Google Scholar
• Wagner M., Gutermann A., Podlech J., Reddehase M. J., Koszinowski U. H. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. J Exp Med 2002; 196: 805–816
   Google Scholar
• Hengel H., Reusch U., Geginat G., Holtappels R., Ruppert T., Hellebrand E., Koszinowski U. H. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. J Virol 2000; 74: 7861–7868
   Google Scholar
• Barel M. T., Hassink G. C., van Voorden S., Wiertz E. J. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation. Mol Immunol 2006; 43: 1258–1266
   Google Scholar
• Shamu C. E., Story C. M., Rapoport T. A., Ploegh H. L. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol 1999; 147: 45–58
   PubMed Web of Science ®Google Scholar
• Vittone V., Diefenbach E., Triffett D., Douglas M. W., Cunningham A. L., Diefenbach R. J. Determination of interactions between tegument proteins of herpes simplex virus type 1. J Virol 2005; 79: 9566–9571
   PubMed Web of Science ®Google Scholar
• Ye Y., Shibata Y., Yun C., Ron D., Rapoport T. A. A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 2004; 429: 841–847
   PubMed Web of Science ®Google Scholar
• Radosevich T. J., Seregina T., Link C. J. Effective suppression of class I major histocompatibility complex expression by the US11 or ICP47 genes can be limited by cell type or interferon-gamma exposure. Hum Gene Ther 2003; 14: 1765–1775
   Google Scholar
• Fiebiger E., Story C., Ploegh H. L., Tortorella D. Visualization of the ER-to-cytosol dislocation reaction of a type I membrane protein. Embo J 2002; 21: 1041–1053
   PubMed Web of Science ®Google Scholar
• Hengel H., Flohr T., Hammerling G. J., Koszinowski U. H., Momburg F. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. J Gen Virol 1996; 77: 2287–2296
   Google Scholar
• Lilley B. N., Ploegh H. L. A membrane protein required for dislocation of misfolded proteins from the ER. Nature 2004; 429: 834–840
   PubMed Web of Science ®Google Scholar
• Loch S., Tampe R. Viral evasion of the MHC class I antigen-processing machinery. Pflugers Arch 2005; 451: 409–417
   Google Scholar
• Boehm U., Klamp T., Groot M., Howard J. C. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749–795
   PubMed Web of Science ®Google Scholar
• Morrison T. E., Mauser A., Wong A., Ting J. P., Kenney S. C. Inhibition of IFN-gamma signaling by an Epstein-Barr virus immediate-early protein. Immunity 2001; 15: 787–799
   PubMed Web of Science ®Google Scholar
• Barnes B., Lubyova B., Pitha P. M. On the role of IRF in host defense. J Interferon Cytokine Res 2002; 22: 59–71
   PubMed Web of Science ®Google Scholar
• Fuld S., Cunningham C., Klucher K., Davison A. J., Blackbourn D. J. Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. J Virol 2006; 80: 3092–3097
   PubMedGoogle Scholar
• Paulson M., Pisharody S., Pan L., Guadagno S., Mui A. L., Levy D. E. Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J Biol Chem 1999; 274: 25343–25349
   PubMed Web of Science ®Google Scholar
• Gotoh B., Komatsu T., Takeuchi K., Yokoo J. The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology 2003; 316: 29–40
   Google Scholar
• Malkas L. H., Hickey R. J., Li C., Pedersen N., Baril E. F. A 21S enzyme complex from HeLa cells that functions in simian virus 40 DNA replication in vitro. Biochemistry 1990; 29: 6362–6374
   PubMed Web of Science ®Google Scholar
• Ishimi Y., Claude A., Bullock P., Hurwitz J. Complete enzymatic synthesis of DNA containing the SV40 origin of replication. J Biol Chem 1988; 263: 19723–19733
   PubMedGoogle Scholar
• Gribaudo G., Lembo D., Cavallo G., Landolfo S., Lengyel P. Interferon action: binding of viral RNA to the 40-kilodalton 2′-5′-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus. J Virol 1991; 65: 1748–1757
   PubMedGoogle Scholar
• Yuan W., Aramini J. M., Montelione G. T., Krug R. M. Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: A protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 2002; 304: 291–301
   Google Scholar
• Yuan W., Krug R. M. Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. Embo J 2001; 20: 362–371
   PubMedGoogle Scholar
• Taylor G. S., Rickinson A. B. Antigens and Autophagy: The Path Less Travelled By?. Autophagy 2007; 3: 60–62
   PubMed Web of Science ®Google Scholar
• Ben-Asouli Y., Banai Y., Pel-Or Y., Shir A., Kaempfer R. Human interferon-gamma mRNA autoregulates its translation through a pseudoknot that activates the interferon-inducible protein kinase PKR. Cell 2002; 108: 221–232
   PubMedGoogle Scholar
• Wong A. H., Durbin J. E., Li S., Dever T. E., Decker T., Koromilas A. E. Enhanced antiviral and antiproliferative properties of a STAT1 mutant unable to interact with the protein kinase PKR. J Biol Chem 2001; 276: 13727–13737
   PubMedGoogle Scholar
• Pang Q., Keeble W., Diaz J., Christianson T. A., Fagerlie S., Rathbun K., et al. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon gamma, tumor necrosis factor-alpha, and double-stranded RNA. Blood 2001; 97: 1644–1652
   Google Scholar
• Koromilas A. E., Cantin C., Craig A. W., Jagus R., Hiscott J., Sonenberg N. The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin kappa gene. J Biol Chem 1995; 270: 25426–25434
   PubMedGoogle Scholar
• Gil J., Esteban M. The interferon-induced protein kinase (PKR), triggers apoptosis through FADD-mediated activation of caspase 8 in a manner independent of Fas and TNF-alpha receptors. Oncogene 2000; 19: 3665–3674
   PubMed Web of Science ®Google Scholar
• Nakamura H., Li M., Zarycki J., Jung J. U. Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol 2001; 75: 7572–7582
   PubMed Web of Science ®Google Scholar
• Baran-Marszak F., Feuillard J., Najjar I., Le Clorennec C., Bechet J. M., Dusanter-Fourt I., et al. Differential roles of STAT1alpha and STAT1beta in fludarabine-induced cell cycle arrest and apoptosis in human B cells. Blood 2004; 104: 2475–2483
   PubMed Web of Science ®Google Scholar
• Barber G. N. Host defense, viruses and apoptosis. Cell Death Differ 2001; 8: 113–126
   PubMed Web of Science ®Google Scholar
• Lo A. K., Lo K. W., Tsao S. W., Wong H. L., Hui J. W., To K. F., et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 2006; 8: 173–180
   PubMed Web of Science ®Google Scholar
• Watanabe M. A., de Souza L. R., Murad J. M., De Lucca F. L. Activation of the RNA-dependent protein kinase (PKR) of lymphocytes by regulatory RNAs: Implications for immunomodulation in HIV infection. Curr HIV Res 2005; 3: 329–337
   Google Scholar
• Cai R., Carpick B., Chun R. F., Jeang K. T., Williams B. R. HIV-I TAT inhibits PKR activity by both RNA-dependent and RNA-independent mechanisms. Arch Biochem Biophys 2000; 373: 361–367
   PubMed Web of Science ®Google Scholar
• Lee T. G., Tang N., Thompson S., Miller J., Katze M. G. The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol 1994; 14: 2331–2342
   PubMedGoogle Scholar
• Williams B. R. PKR: A sentinel kinase for cellular stress. Oncogene 1999; 18: 6112–6120
   PubMed Web of Science ®Google Scholar
• Mulvey M., Poppers J., Sternberg D., Mohr I. Regulation of eIF2alpha phosphorylation by different functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J Virol 2003; 77: 10917–10928
   PubMed Web of Science ®Google Scholar
• Mohr I. Neutralizing innate host defenses to control viral translation in HSV-1 infected cells. Int Rev Immunol 2004; 23: 199–220
   PubMed Web of Science ®Google Scholar
• Gunnery S., Mathews M. B. RNA binding and modulation of PKR activity. Methods 1998; 15: 189–198
   Google Scholar
• Mulvey M., Poppers J., Ladd A., Mohr I. A herpesvirus ribosome-associated, RNA-binding protein confers a growth advantage upon mutants deficient in a GADD34-related function. J Virol 1999; 73: 3375–3385
   Google Scholar
• Li S., Labrecque S., Gauzzi M. C., Cuddihy A. R., Wong A. H., Pellegrini S., et al. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 1999; 18: 5727–5737
   PubMed Web of Science ®Google Scholar
• Zanier K., Charbonnier S., Baltzinger M., Nomine Y., Altschuh D., Trave G. Kinetic analysis of the interactions of human papillomavirus E6 oncoproteins with the ubiquitin ligase E6AP using surface plasmon resonance. J Mol Biol 2005; 349: 401–412
   PubMedGoogle Scholar
• Um S. J., Rhyu J. W., Kim E. J., Jeon K. C., Hwang E. S., Park J. S. Abrogation of IRF-1 response by high-risk HPV E7 protein in vivo. Cancer Lett 2002; 179: 205–212
   PubMed Web of Science ®Google Scholar
• Park J. S., Kim E. J., Kwon H. J., Hwang E. S., Namkoong S. E., Um S. J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J Biol Chem 2000; 275: 6764–6769
   PubMed Web of Science ®Google Scholar
• Nusinzon I., Horvath C. M. Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc Natl Acad Sci U S A 2003; 100: 14742–14747
   PubMed Web of Science ®Google Scholar
• Nguyen D. X., Westbrook T. F., McCance D. J. Human papillomavirus type 16 E7 maintains elevated levels of the cdc25A tyrosine phosphatase during deregulation of cell cycle arrest. J Virol 2002; 76: 619–632
   PubMed Web of Science ®Google Scholar
• Georgopoulos N. T., Proffitt J. L., Blair G. E. Transcriptional regulation of the major histocompatibility complex (MHC) class I heavy chain, TAP1 and LMP2 genes by the human papillomavirus (HPV) type 6b, 16 and 18 E7 oncoproteins. Oncogene 2000; 19: 4930–4935
   PubMed Web of Science ®Google Scholar
• Kao W. H., Beaudenon S. L., Talis A. L., Huibregtse J. M., Howley P. M. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J Virol 2000; 74: 6408–6417
   PubMedGoogle Scholar
• Seo T., Lee D., Lee B., Chung J. H., Choe J. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein. Biochem Biophys Res Commun 2000; 270: 23–27
   Google Scholar
• Lubyova B., Kellum M. J., Frisancho A. J., Pitha P. M. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 2004; 279: 7643–7654
   PubMedGoogle Scholar